The effects of different treatments on prolidase and antioxidant enzyme activities in patients with bronchial asthma

Environmental Toxicology and Pharmacology

Volumn 22, Issue 1, 2006, Pages 35-39

  Kaleli, Süleyman ^a   Akkaya, Ahmet ^b   Akdogan, Mehmet ^b   Gültekin, Fatih ^b  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antioxidant system; Bronchial asthma; Prolidase; Treatment

Indexed keywords

ANTIOXIDANT; BUDESONIDE PLUS FORMOTEROL; CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MONTELUKAST; PROLINE DIPEPTIDASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; ASTHMA; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEFENSE MECHANISM; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

NEPTUNIA;

EID: 33646759204     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2005.11.001     Document Type: Article

References (32)

1. Abraham P., Wilfred G., and Ramakrisna B. Plasma prolidase may be an index of liver fibrosis in the rat. Clin. Chim. Acta 295 (2000) 199-202
2. Aebi H. Catalase in vitro. Method. Enzymol. 105 (1984) 121-126
3. Aziz I., Wilson A.M., and Lipworth B.J. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults. Chest 118 (2000) 1049-1058
4. Beck-Speier I., Dayal N., Karg E., Maier K.L., Schumann G., Schulz H., Semler M., Takenaka S., Stettmaier K., Bors W., Ghio A., Samet J.M., and Heyder J. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic. Biol. Med. 38 (2005) 1080-1092
5. Bianchi A., Dewailly E., Gautier H., Merlin J.L., Slomianny C., Dauça M., and Bécuwe Ph. Decrease of human hepatoma cell growth by arachidonic acid is associated with an accumulation of derived products from lipid peroxidation. Biochimie 86 (2004) 633-642
6. Boulet L.P., Turcotte H., Laviolette M., Naud F., Bernier M.C., Martel S., and Chakir J. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 162 (2000) 1308-1313
7. Cantin P.A. Oxidant and antioxidants in lung injury. In: Moss J. (Ed). Lam and Other Diseases Characterized by Smooth Muscle Proliferation (1999), Marcel Decker Publisher, New York, NY 519-531
8. Drapper H.H., and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Method Enzymol. 186 (1990) 421-431
9. Escobar J.A., Rubio M.A., and Lissi E.A. SOD and catalase inactivation by singlet oxygen and peroxyl radicals. Free Radic. Biol. Med. 20 (1996) 285-290
10. Fattman C.L., Schaefer L.M., and Oury T.D. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35 (2003) 236-256
11. Fenech A.G., and Ellul-Micallef R. Selenium, glutathione peroxidase and superoxide dismutase in maltese asthmatic patients: effect of glucocorticoid administration. Pulm. Pharmacol. Ther. 11 (1998) 301-308
12. Filip F., Branisteanu D., Popovici I., Jerca L., Topoliceanu F., Mancas G., Sarmasan V., Vartolomei M., Jerca O., and Busuioc D. The blood enzymatic antioxidative potential in bronchial asthma patients. Rev. Med. Chir. Soc. Med. Nat. Iasi. 103 (1999) 153-157
13. Ghiro L., Zanconato S., Rampon O., Piovan V., Pasquale M.F., and Baraldi E. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children. Eur. Respir. J. 20 (2002) 630-634
14. Gong Jr. H., Linn W.S., Terrell S.L., Anderson K.R., and Clark K.W. Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide. Chest 119 (2001) 402-408
15. Hastie A.T., Kraft W.K., Nyce K.B., Zangrilli J.G., Musani A.I., Fish J.E., and Peters S.P. Asthmatic epithelial cell proliferation and stimulation of collagen production: human asthmatic epithelial cells stimulate collagen type III production by human lung myofibroblasts after segmental allergen challenge. Am. J. Respir. Crit. Care 165 (2002) 266-272
16. Lenz A.-G., Hinze-Heyn H., Schneider A., Behr J., Häußinger K., Heindl S., Stanzel F., and Maier K.L. Influence of inflammatory mechanisms on the redox balance in interstitial lung diseases. Respir. Med. 98 (2004) 737-745
17. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur. J. Pharmacol. 429 (2001) 195-207
18. Majori M., Vachier I., Godard P., Farce M., Bousquet J., and Chanez P. Superoxide anion production by monocytes of corticosteroid-treated asthmatic patients. Eur. Respir. J. 11 (1998) 133-138
19. Meyer K.C. Beryllium and lung disease. Chest 106 (1994) 942-946
20. Morishima Y., Nomura A., Uchida Y., Noguchi Y., Sakamoto T., Ishii Y., Goto Y., Masuyama K., Zhang M.J., Hirano K., Mochizuki M., Ohtsuka M., and Sekizawa K. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am. J. Respir. Cell Mol. 24 (2001) 1-11
21. Myara I., Charpentier C., and Lemonnier A. Prolidase and prolidase deficiency. Life Sci. 34 (1984) 1985-1998
22. Myara I., Myara A., Mangeot M., Fabre M., Charpentier C., and Lemonnier A. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin. Chem. 30 (1984) 211-216
23. Novak Z., Nemeth I., Gyurkovits K., Varga S.I., and Matkovics B. Examination of the role of oxygen free radicals in bronchial asthma in childhood. Clin. Chim. Acta 30 201 (1991) 247-251
24. Oner P., Gurdol F., Oner-Iyidon Y., Kolanci C., and Buyukozturk S. Evaluation of the effect of low-dose oral theophylline therapy on some bone turnover markers and serum prolidase I activity in mild asthmatics. Pharmacol. Res. 40 (1999) 189-193
25. Powell C.V., Nash A.A., Powers H.J., and Primhak R.A. Antioxidant status in asthma. Pediatr. Pulmonol. 18 (1994) 34-38
26. Rahman I., and MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am. J. Physiol. Lung Cell 277 (1999) L1067-L1088
27. Riccioni G., Ballone E., D'Orazio N., Sensi S., Di Nicola M., Di Mascio R., Santilli F., Guagnano M.T., and Della Vecchia R. Effectiveness of montelukast versus budesonide on quality of life and bronchial reactivity in subjects with mild-persistent asthma. Int. J. Immunopathol. Pharmacol. 15 (2002) 149-155
28. Smith L.J., Shamsuddin M., Sporn P.H.S., Denenberg M., and Anderson J. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic. Biol. Med. 22 (1997) 1301-1307
29. Tekin D., Sin B.A., Mungan D., Misirligil Z., and Yavuzer S. The antioxidative defense in asthma. J. Asthma 7 (2000) 59-63
30. Vallyathan V., and Shi X. The role of oxygen free radicals in occupational and environmental lung diseases. Environ. Health Perspect. 105 (1997) 165-177
31. Varshavskii B., Trubnikov G.V., Galaktipmpva L.P., Koreniak N.A., Koledeznaia I.L., and Oberemok A.N. Oxidant-antioxidant status of patients with bronchial asthma during inhalation and systemic glucocorticoid therapy. Ter. Arkh. 75 (2003) 21-24
32. Yaron A., and Naider F. Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. 28 (1993) 31-81